Addressing heart failure must be considered a global health priority because poor awareness of the disease leads to many premature deaths. Approximately 26 million people are living with heart failure worldwide, and if current trends continue the disease will impose ever-increasing burdens on patients, caregivers and healthcare systems.
As #MedicalCommunications and #Publications professionals, how do we bring diversity to our work and how do we achieve it? Today at #ISMPP17AM, our CEO @ChrisW_PharmaG joins a panel on 'Equity, diversity, and inclusion: defining a roadmap for our profession' 10am (EST)/3pm (BST) https://t.co/PxOijPTmh5
Medical Affairs drives many activities in pharma – but it can bring unique challenges. We're leading an @ISMPP session to help you develop #MedicalAffairs leadership skills and succeed in cross-collaboration. Visit here for more information: https://t.co/UMWOOs5UIt #ISMPP17AM https://t.co/8KCjRLIIz6
12th April 2021
Virtual 17th Annual Meeting of ISMPP
Oxford PharmaGenesis is sponsoring this year's meeting of International Society for Medical Publication Professionals (ISMPP). We're taking part in discussions and debates on evolving issues for HealthScience such as Open Access, preprint, and Artificial Intelligence.
Recent announcements regarding Government investments in Oxfordshire are good news for those working within biosciences in the county.